The latest price target for Humana (NYSE:HUM) was reported by Evercore ISI Group on June 11, 2026. The analyst firm set a price target for $370.00 expecting HUM to rise to within 12 months (a possible 0.14% upside). 58 analyst firms have reported ratings in the last year.

The latest analyst rating for Humana (NYSE:HUM) was provided by Evercore ISI Group, and Humana maintained their in-line rating.

The last upgrade for Humana Inc happened on May 20, 2026 when Deutsche Bank raised their price target to $441. Deutsche Bank previously had a hold for Humana Inc.

The last downgrade for Humana Inc happened on February 12, 2026 when RBC Capital changed their price target from $322 to $189 for Humana Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Humana, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Humana was filed on June 11, 2026 so you should expect the next rating to be made available sometime around June 11, 2027.

While ratings are subjective and will change, the latest Humana (HUM) rating was a maintained with a price target of $250.00 to $370.00. The current price Humana (HUM) is trading at is $369.49, which is within the analyst’s predicted range.